DS

Dominik Schumacher

CEO

Tubulis GmbH

Munich, Bavaria


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Tubulis GmbH
Industry
research
Employees
65.0
Seniority
C suite
Annual Revenue
75000000.0
Total Funding
215529054.0
Latest Funding
Series B

Technologies

Outlook Vimeo Google Tag Manager Apache Google Font API Google Analytics Mobile Friendly WordPress.org IoT AI

Keywords

targeted therapy drug development antibody drug conjugates & targeted therapy antibody drug conjugates biotechnology biotechnology research adcs bioconjugation oncology treatments targeted therapeutics pipelines pharmaceutical innovation clinical trials immunotherapy cancer indications payload delivery linker technology cysteine-selective conjugation therapeutic window biophysical properties stability cancer research investigational drugs target biology clinical pharmacokinetics patient benefit biotech innovations phase i studies fast track designation solid tumors patient safety unique conjugation technologies drug-to-antibody ratio therapeutic potential clinical efficacy preclinical models drug stability treatment outcomes solid tumor targets chemistry phase ii trials biotechnology partnerships customizable adcs research team platform technologies drug candidates drug discovery neoadjuvant therapy cancer treatment options multidisciplinary team clinical efficacy study in-vivo potency pharmaceutical collaborations health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans